Human immunodeficiency virus infection and subsequent melanoma

Gabriel M. Kind*, Jamie VonRoenn, David A. Jansen, M. Hugh Bailey, Victor L. Lewis

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


Immunosuppression has been known for many years to be associated with the development of skin cancer, particularly squamous cell carcinoma. The association with melanoma is less clear. This report describes 4 patients with known human immunodeficiency virus (HIV) positivity who subsequently developed malignant melanoma. The subtypes and precursors of the tumors vary. Three of 4 patients treated using accepted surgical standards remained disease free an average of 33 months postoperatively. Treatment of the melanoma as in the non-HIV infected melanoma patient is advised. Epidemiological studies remain to be done to determine the significance of this association. In the meantime, melanoma remains a surgical disease and early, aggressive, standard surgical treatment is encouraged for these patients. Despite the immunocompromised state that their HIV status implies, surgical treatment offers local and regional control of disease and possibly cure.

Original languageEnglish (US)
Pages (from-to)273-277
Number of pages5
JournalAnnals of plastic surgery
Issue number3
StatePublished - Sep 1996

ASJC Scopus subject areas

  • Surgery


Dive into the research topics of 'Human immunodeficiency virus infection and subsequent melanoma'. Together they form a unique fingerprint.

Cite this